Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -15.91% vs -4.52% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,133.33% vs -127.27% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -53.17% vs -23.17% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -23.81% vs 16.67% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -15.91% vs -4.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -15.11% vs 36.55% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 1,133.33% vs -127.27% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6.90% vs 128.71% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -53.17% vs -23.17% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.42% vs 223.96% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -23.81% vs 16.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 23.08% vs -18.75% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






